Revelation Biosciences Inc (FRA:56U0)
€ 8.88 0 (0%) Market Cap: 3.05 Mil Enterprise Value: 8.79 Mil PE Ratio: 0 PB Ratio: 0.32 GF Score: 24/100

Revelation Biosciences Inc at ROTH Conference Transcript

Mar 14, 2023 / 07:30PM GMT
Release Date Price: €56.7 (+19.32%)
Jonathan Aschoff
ROTH Capital Partners, LLC - Analyst

Hello, welcome back. I'm Jonathan Aschoff, senior biotechnology analyst at ROTH MKM. And with me is James Rolke, the CEO of Revelation Biosciences. And welcome, James. Nice to have you.

James Rolke
Revelation Biosciences, Inc. - Director & CEO

Yeah, thanks for having me.

Jonathan Aschoff
ROTH Capital Partners, LLC - Analyst

I'm going to start you off with -- tell us a little bit about both of your lead programs, 100 and 300.

James Rolke
Revelation Biosciences, Inc. - Director & CEO

Yeah, great. Thanks. So just for the audience and for the people that are joining via their webcam, I'm going to cover a lot of information, I'm sure, as we go back and forth here and you can probably find a lot of what I'm going to tell you, including the data, on our website at revbiosciences.com. That's revbiosciences.com.

So yeah -- so I'm also very excited to tell you about our lead programs because I feel very

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot